Cardiovascular Disease Doctors in Augusta, GA Accepting Medicare

47 Cardiovascular Disease doctors found. Showing 41 - 47

Arthur Bleakley Chandler Jr., M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1350 Walton Way, Augusta, GA 30901 Phone: 706-774-7855    Fax: 706-774-2152

Mahendra K. Mandawat, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 706-721-2426

John Thornton, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1120 15th Street, Augusta, GA 30912 Phone: 706-721-2426

Sameh Z. Lamiy, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 818 Saint Sebastian Way Ste 311, Augusta, GA 30901 Phone: 706-724-3473    Fax: 706-724-3493

Mac A Bowman, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 818 Saint Sebastian Way, Suite 308, Augusta, GA 30901 Phone: 706-724-4400    Fax: 706-724-6003

Dr. Sean P Javaheri, D.O. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 706-724-6100

Daniel Aaron Sohinki, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 706-721-8623    Fax: 706-721-1459

News Archive

EMA accepts Pfizer's regulatory submissions of two investigational cancer drugs for review

Pfizer Inc. announced today that the European Medicines Agency (EMA) has accepted Pfizer's regulatory submissions for review of two investigational compounds - crizotinib, an oral first-in-class anaplastic lymphoma kinase (ALK) inhibitor, for the treatment of patients with previously treated ALK-positive advanced non-small cell lung cancer (NSCLC); and bosutinib for the treatment of adult patients with newly diagnosed Philadelphia chromosome positive (Ph+) chronic myeloid leukemia (CML) in the chronic phase.

Study reveals increased mortality risk following hypertensive disease of pregnancy

In a study to be presented on Feb. 5 at 8 a.m. EST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in Atlanta, researchers will present findings from a study titled, Long-term mortality risk following hypertensive disease of pregnancy (HDP).

Phase 3 study of idelalisibin reports positive results in CLL patients

Following a recommendation by an independent Data Monitoring Committee (DMC), Gilead Sciences, Inc. (Nasdaq:GILD) today announced that its Phase 3 study (Study 116) evaluating idelalisib in previously-treated chronic lymphocytic leukemia (CLL) patients who are not fit for chemotherapy will be stopped early.

New imaging system offers better way to monitor brain changes from Alzheimer's in mouse models

An estimated 5.5 million Americans live with Alzheimer's disease, a type of dementia that causes problems with memory, thinking and behavior. Although treatments can slow the worsening of symptoms, scientists are still working to better understand the neurodegenerative disease so that curative and preventative medicines can be developed.

Read more Medical News

› Verified 9 days ago

• 1
• 2
• 3(current)